| Primary |
| Depression |
27.3% |
| Drug Use For Unknown Indication |
27.3% |
| Increased Appetite |
9.1% |
| Migraine |
9.1% |
| Tremor |
9.1% |
| Decreased Appetite |
4.5% |
| Migraine Prophylaxis |
4.5% |
| Sleep Disorder |
4.5% |
| Suicide Attempt |
4.5% |
|
| Dysuria |
8.3% |
| Libido Increased |
8.3% |
| Myoclonus |
8.3% |
| Poisoning |
8.3% |
| Respiratory Arrest |
8.3% |
| Serotonin Syndrome |
8.3% |
| Social Problem |
8.3% |
| Somnolence |
8.3% |
| Suicidal Ideation |
8.3% |
| Suicide Attempt |
8.3% |
| Tremor |
8.3% |
| Virilism |
8.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
57.1% |
| Fatigue |
6.0% |
| Convulsion Prophylaxis |
4.8% |
| Product Used For Unknown Indication |
4.8% |
| Suicide Attempt |
4.2% |
| Diabetes Mellitus |
3.6% |
| Completed Suicide |
3.0% |
| Convulsion |
3.0% |
| Apathy |
2.4% |
| Gastroenteritis |
1.8% |
| Tremor |
1.8% |
| Atrial Fibrillation |
1.2% |
| Blood Pressure Management |
1.2% |
| Headache |
1.2% |
| Post-traumatic Epilepsy |
1.2% |
| Angina Pectoris |
0.6% |
| Anxiety |
0.6% |
| Attention Deficit/hyperactivity Disorder |
0.6% |
| Bronchitis Acute |
0.6% |
| Chronic Obstructive Pulmonary Disease |
0.6% |
|
| Completed Suicide |
14.0% |
| Nausea |
14.0% |
| Oral Intake Reduced |
9.3% |
| Respiratory Arrest |
9.3% |
| Vomiting |
9.3% |
| Drug Abuse |
7.0% |
| Death |
4.7% |
| Drug Toxicity |
4.7% |
| Cardio-respiratory Arrest |
2.3% |
| Drug Hypersensitivity |
2.3% |
| Erythema Multiforme |
2.3% |
| Insomnia |
2.3% |
| Liver Transplant |
2.3% |
| Overdose |
2.3% |
| Paranoia |
2.3% |
| Parkinsonism |
2.3% |
| Pyrexia |
2.3% |
| Renal Failure |
2.3% |
| Renal Impairment |
2.3% |
| Serotonin Syndrome |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.3% |
| Drug Use For Unknown Indication |
25.2% |
| Colorectal Cancer Metastatic |
6.8% |
| Pain |
4.9% |
| Diagnostic Procedure |
3.3% |
| Colon Cancer |
2.6% |
| Neuroendocrine Tumour |
2.3% |
| Multiple Myeloma |
2.2% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Non-small Cell Lung Cancer |
2.1% |
| Attention Deficit/hyperactivity Disorder |
2.0% |
| Osteoporosis |
2.0% |
| Prostate Cancer |
2.0% |
| Constipation |
1.9% |
| Depression |
1.8% |
| Hepatitis C |
1.8% |
| Migraine |
1.8% |
| Asthma |
1.7% |
| Prophylaxis |
1.7% |
| Rheumatoid Arthritis |
1.6% |
|
| Vomiting |
27.2% |
| Weight Decreased |
13.2% |
| Nausea |
8.1% |
| Death |
6.6% |
| Electrocardiogram Qt Prolonged |
3.7% |
| Urinary Tract Infection |
3.7% |
| Asthenia |
2.9% |
| Headache |
2.9% |
| Macular Oedema |
2.9% |
| Product Quality Issue |
2.9% |
| Rash |
2.9% |
| Thrombocytopenia |
2.9% |
| Urticaria |
2.9% |
| Vision Blurred |
2.9% |
| Weight Increased |
2.9% |
| Alanine Aminotransferase Increased |
2.2% |
| Anaemia |
2.2% |
| Arthralgia |
2.2% |
| Crohn's Disease |
2.2% |
| Erythema Multiforme |
2.2% |
|
| Interacting |
| Dyspepsia |
14.1% |
| Gastrooesophageal Reflux Disease |
14.1% |
| Anxiety |
9.4% |
| Depression |
9.4% |
| Hypothyroidism |
8.6% |
| Panic Attack |
8.6% |
| Irritable Bowel Syndrome |
7.8% |
| Anorexia |
4.7% |
| Appetite Disorder |
4.7% |
| Hypersensitivity |
4.7% |
| Increased Appetite |
4.7% |
| Sleep Disorder |
4.7% |
| Stomach Discomfort |
4.7% |
|
|
